Mentioned:
Enhanced Group wants to be a first mover in the future of longevity protocols. Which is exactly why Christian Angermayer is pouring millions of dollars into a new financing round.
What’s happening:
- Enhanced Group (NYSE: ENHA) has successfully raised $50M USD in a new equity financing round
By the numbers:
- Enhanced Group issued roughly 12.8M common shares at a price of $3.89 USD per share
- Enhanced Group also issued 12.8M warrants at a strike price of $3.89 USD as part of the new financing round
Why it matters:
- The new $50M USD financing round was led by prominent billionaire entrepreneur and investor Christian Angermayer through his family office Apeiron Investment Group
Going deeper:
- Christian Angermayer is notably a co-founder of Enhanced Group as well as a co-founder of psychedelic drug development company AtaiBeckley (NASDAQ: ATAI) which he owns roughly 51M common shares of through multiple strategic investments
- Enhanced Group is aiming to become one of the leading publicly traded companies focused on providing individuals with access to protocols for optimizing health and longevity and previously completed a SPAC deal with A Paradise Acquisition Corp to list on the New York Stock Exchange
